Ocular manifestations in ANCA-associated vasculitis: a comprehensive analysis from Chinese medical centers

被引:1
作者
Liu, Shulin [1 ]
Xu, Mei [1 ]
Zhao, Xinyu [2 ]
Yang, Jingyuan [2 ]
Zhang, Wenfei [2 ]
Chen, Youxin [2 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Chongqing Key Lab Prevent & Treatment Major Blindi, Chongqing, Peoples R China
[2] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Ophthalmol, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
ANCA-associated vasculitis; Eosinophilic granulomatosis with polyangiitis; Granulomatosis with polyangiitis; Microscopic polyangiitis; Ocular manifestations; CHURG-STRAUSS-SYNDROME; RHEUMATOLOGY; 1990; CRITERIA; AMERICAN-COLLEGE; WEGENER GRANULOMATOSIS; CLASSIFICATION; DISEASE; CYCLOPHOSPHAMIDE; NOMENCLATURE;
D O I
10.1007/s10067-024-07034-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionThis study aimed to explore ocular manifestations in ANCA-associated vasculitis (AAV), focusing on granulomatosis with polyangiitis (GPA), eosinophilic granulomatosis with polyangiitis (EGPA), and microscopic polyangiitis (MPA) and to examine the associations with laboratory parameters and other systemic manifestations.MethodsThis retrospective study reviewed data from 533 AAV patients across two major Chinese medical centers from January 2016 to November 2023. Data including diagnosis, cranial manifestations of disease, ocular complications, and laboratory parameters were analyzed. Univariate and multivariable logistic regression analyses assessed associations across disease manifestations. Machine learning models were also utilized to predict the risk of retinal/eye involvement in AAV patients.ResultsAmong 533 patients (210 GPA, 217 MPA, 99 EGPA, and 7 unclassified AAV), ocular complications were observed in 20.64% of them, with a distribution of 36.67% in GPA, 7.37% in MPA, and 18.18% in EGPA. The most common ocular manifestations included scleritis and retro-orbital mass/dacryocystitis, which were notably prevalent in GPA patients. Retinal involvement was observed in 9.09% of EGPA cases. The machine learning models yielded that eosinophil percentage (EOS%), high-sensitivity C-reactive protein (hsCRP), and CD4 + T cell/CD8 + T cell ratio (T4/T8) can predict retinal involvement. Furthermore, the white blood cell, EOS%, APTT, IgA, hsCRP, PR3-ANCA, and T4/T8 can predict eye involvement.ConclusionOcular manifestations are a prevalent complication across all forms of AAV. Predictive models developed through machine learning offer promising tools for early intervention and tailored patient care. This necessitates a multidisciplinary approach, integrating rheumatology and ophthalmology expertise for optimal patient outcomes.
引用
收藏
页码:2899 / 2910
页数:12
相关论文
共 50 条
[21]   Salivary gland involvement in ANCA-associated vasculitis [J].
Akiyama, Mitsuhiro ;
Takanashi, Satoshi ;
Takeuchi, Tsutomu ;
Kaneko, Yuko .
AUTOIMMUNITY REVIEWS, 2021, 20 (11)
[22]   Renal outcome of kidney-transplantation in Korean recipients with ANCA-associated vasculitis [J].
Park, E. S. ;
Ahn, S. S. ;
Jung, S. M. ;
Song, J. J. ;
Park, Y. -B. ;
Lee, S. -W. .
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (02) :S115-S120
[23]   Increasing incidence and prevalence of ANCA-associated vasculitis in Northern Norway [J].
Nilsen, Aksel Thuv ;
Karlsen, Christine ;
Bakland, Gunnstein ;
Watts, Richard ;
Luqmani, Raashid ;
Koldingsnes, Wenche .
RHEUMATOLOGY, 2020, 59 (09) :2316-2324
[24]   ANCA-negative ANCA-associated vasculitis: pitfalls of the 'vasculitis screen' [J].
Cooke, Hannah ;
Wells, Matthew ;
Miller, Keith ;
Medford, Andrew R. L. ;
Patel, Sam .
CLINICAL MEDICINE, 2023, 23 (06) :630-632
[25]   ANCA-Associated Vasculitis Pathogenesis: A Commentary [J].
Eric J. Gapud ;
Philip Seo ;
Brendan Antiochos .
Current Rheumatology Reports, 2017, 19
[26]   Application of RIFLE criteria in Chinese patients with ANCA-associated renal vasculitis [J].
Chen, Y-X ;
Zhang, W. ;
Chen, X-N ;
Shen, P-Y ;
Shi, H. ;
Xu, Y-W ;
Ren, H. ;
Chen, N. .
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (06) :951-957
[27]   Advances in Therapy for ANCA-Associated Vasculitis [J].
Geetha, Duvuru ;
Seo, Philip .
CURRENT RHEUMATOLOGY REPORTS, 2012, 14 (06) :509-515
[28]   Advances in Therapy for ANCA-Associated Vasculitis [J].
Duvuru Geetha ;
Philip Seo .
Current Rheumatology Reports, 2012, 14 :509-515
[29]   ANCA-Associated Vasculitis Pathogenesis: A Commentary [J].
Gapud, Eric J. ;
Seo, Philip ;
Antiochos, Brendan .
CURRENT RHEUMATOLOGY REPORTS, 2017, 19 (04)
[30]   Explaining fatigue in ANCA-associated vasculitis [J].
Basu, Neil ;
McClean, Andrew ;
Harper, Lorraine ;
Amft, Esther N. ;
Dhaun, Neeraj ;
Luqmani, Raashid A. ;
Little, Mark A. ;
Jayne, David R. W. ;
Flossmann, Oliver ;
McLaren, John ;
Kumar, Vinod ;
Erwig, Lars P. ;
Reid, David M. ;
Macfarlane, Gary J. ;
Jones, Gareth T. .
RHEUMATOLOGY, 2013, 52 (09) :1680-1685